Frec Markets’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$367K Sell
9,679
-666
-6% -$30.7K 0.02% 772
2026
Q2
$496K Buy
10,345
+2,970
+40% +$128K 0.04% 511
2026
Q1
$271K Buy
7,375
+1,141
+18% +$54.1K 0.05% 468
2025
Q4
$317K Buy
+6,234
New +$319K 0.09% 220

Other funds holding NVO

Frec Markets's NVO Position: Q3 2026 in Review

Frec Markets reduced its Novo Nordisk (NVO) stake by 6.4% in Q3 2026, selling an estimated $30.7K and leaving 9,679 shares worth $367K. The position accounts for 0.02% of the portfolio, ranked #772.

Frec Markets first reported a position in NVO in Q4 2025 and has held it in 4 quarters since. The position peaked at $496K in Q2 2026. 1,220 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Frec Markets held 9,679 shares of Novo Nordisk worth $367K as of Q3 2026.
  • Frec Markets sold 666 Novo Nordisk shares in Q3 2026, an estimated $30.7K.
  • Novo Nordisk made up 0.02% of Frec Markets's portfolio in Q3 2026, its #772 holding.
  • Frec Markets first reported a position in Novo Nordisk in Q4 2025 and has held it in 4 quarters since.
  • Frec Markets's Novo Nordisk position peaked at $496K in Q2 2026.
  • 1,220 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Frec Markets's 13F filing for Q3 2026, filed 16 Nov 2026.